3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Lymphoma
17
Leukemia, Myeloid, Acute
16
Breast Neoplasms
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Multiple Myeloma
12
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma, Non-Hodgkin
11
Carcinoma, Non-Small-Cell Lung
11
Lymphoma, Mantle-Cell
10
Leukemia
10
Lymphoma, Follicular
9
Hodgkin Disease
9
Myelodysplastic Syndromes
8
Recurrence
7
Neuroblastoma
7
Neoplasm Metastasis
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Brain Neoplasms
7
Neoplasms, Plasma Cell
6
Lymphoma, B-Cell, Marginal Zone
6
Lung Neoplasms
6
Glioblastoma
6
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, T-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphoma, B-Cell
5
Immunoblastic Lymphadenopathy
5
Burkitt Lymphoma
5
Interventions
pembrolizumab
5
Paclitaxel
4
Ifosfamide
4
Cisplatin
4
Nivolumab
3
avelumab
2
aldesleukin
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
Adoptive Transfer
2
vinflunine
1
toripalimab
1
rocakinogene sifuplasmid
1
niraparib
1
nimotuzumab
1
lenvatinib
1
enfortumab vedotin
1
durvalumab
1
dostarlimab
1
dacomitinib
1
cemiplimab
1
cabazitaxel
1
Vorinostat
1
VGX-3100
1
Ultrasonography
1
Surveys and Questionnaires
1
Sildenafil Citrate
1
Sentinel Lymph Node Biopsy
1
Psychiatric Rehabilitation
1
Psychiatric Nursing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Penile Neoplasms
×
Vorinostat
×
Clear all
NCT04357873
2025-02-19
PEVOsq
UNICANCER
Phase 2
Completed
112 enrolled